Purchase Order 75F40120P00235
Award Date 6/8/20
Potential Completion Date 8/4/25
Potential Value $284K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Berwyn Heights, MD 20740, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Biomerieux Inc., a global leader in in vitro diagnostics. The $242,002.88 contract is for a service and preventative maintenance agreement for Biomerieux's laboratory instruments. The contract does not have a set-aside designation. Biomerieux, through its Biomerieux, Inc. division, provides a range of clinical diagnostic equipment, reagents, and supplies to various federal agencies,...
- The U.S. Food and Drug Administration (FDA) awarded a $9,659.86 firm-fixed-price delivery order contract to Biomerieux Inc., a global leader in in vitro diagnostics and microbiology testing solutions. The contract, which is not set-aside, provides the FDA with various Biomerieux diagnostic products and consumables, including API 20 E strips, API Listeria, VIDAS Salmonella, VIDAS Listeria, VITEK 2 GN, and VITEK 2 GP. This contract is part of a larger Indefinite Delivery Vehicle (IDV) that...
- This firm-fixed-price federal contract award was issued by the Food and Drug Administration (FDA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the delivery of its specialized consumables. The $1,386.10 contract has a completion date of December 1, 2021. Biomerieux Inc. is providing the FDA with its proprietary diagnostic platforms, reagents, and test kits, which are used for rapid pathogen detection and identification. This award is not associated with any set-aside...
- This is a $70,253.52 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Biomerieux Inc. for preventive maintenance of Vitek MS diagnostic equipment. The contract has an ultimate completion date of June 25, 2025 and does not utilize any set-aside designations. Biomerieux Inc., a global leader in in vitro diagnostics, is the prime contractor and the sole provider of this specialized diagnostic maintenance service for the FDA. The contract is part of Biomerieux's...
- This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of its specialized clinical diagnostic equipment, reagents, and supplies. The $4,243.20 firm-fixed-price contract, awarded by the Food and Drug Administration (FDA), is a delivery order under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle. The contract has an ultimate completion date of September 23, 2024 and does not involve any set-aside designation....
- This is a federal purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Biomerieux Inc., a for-profit manufacturer of diagnostic equipment and laboratory technologies. The purpose of the $170,688.00 firm-fixed-price contract is to provide a service maintenance agreement for a Biomerieux bioinstrumentation system. The contract does not have a set-aside designation, indicating Biomerieux may be considered a sole-source provider of this specialized diagnostic...
- Biomerieux Inc. was awarded a $32,000 delivery order against the Department of Health and Human Services Food and Drug Administration's Indefinite Delivery Indefinite Quantity BIOMERIEUX IDIQ CONTRACT. As the prime contractor, Biomerieux Inc. will provide unspecified products or services to the FDA from its Lakewood, Colorado facility over the one year period of performance beginning December 2023. The firm fixed price contract was awarded through the Biomerieux Inc. Division and does not appear...
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $42,935.88 firm fixed price delivery order to Biomerieux Inc. under an indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The delivery order, which has an anticipated completion date of August 30, 2024 and was awarded on January 12, 2024, is for the provision of Biomerieux products and services to the FDA. No set-aside designation was applied to this award. Place of performance will be in...
- This federal contract award is for a Biochemical Identification System awarded by the Food and Drug Administration (FDA) to Biomerieux Inc., a global leader in in vitro diagnostics. The $103,973.32 firm-fixed-price delivery order is placed under Biomerieux's Federal Supply Schedule (FSS) contract for Scientific Equipment and Services (FSS-66). The contract does not have a set-aside designation. Biomerieux, through its Biomerieux, Inc. division, is providing the FDA with its proprietary...
- The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price purchase order contract to Biomerieux Inc., a division of Biomerieux, Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic solutions. The $56,625.00 contract is for a Bacterial Identification and Monitoring System to be delivered by June 29, 2025. Biomerieux is a global leader in microbiology testing and has provided numerous proprietary diagnostic platforms, reagents, and...